These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26761203)

  • 1. Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption.
    Lampi MC; Faber CJ; Huynh J; Bordeleau F; Zanotelli MR; Reinhart-King CA
    PLoS One; 2016; 11(1):e0147033. PubMed ID: 26761203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
    Zeng L; Xu H; Chew TL; Eng E; Sadeghi MM; Adler S; Kanwar YS; Danesh FR
    FASEB J; 2005 Nov; 19(13):1845-7. PubMed ID: 16160062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition.
    Chen W; Pendyala S; Natarajan V; Garcia JG; Jacobson JR
    Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L575-83. PubMed ID: 18658277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
    Xu H; Zeng L; Peng H; Chen S; Jones J; Chew TL; Sadeghi MM; Kanwar YS; Danesh FR
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F995-1004. PubMed ID: 16774905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin.
    Jacobson JR; Dudek SM; Birukov KG; Ye SQ; Grigoryev DN; Girgis RE; Garcia JG
    Am J Respir Cell Mol Biol; 2004 May; 30(5):662-70. PubMed ID: 14630613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
    Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
    Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.
    Shiga N; Hirano K; Hirano M; Nishimura J; Nawata H; Kanaide H
    Circ Res; 2005 May; 96(9):1014-21. PubMed ID: 15817883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells.
    Rossi J; Rouleau L; Emmott A; Tardif JC; Leask RL
    Eur J Pharmacol; 2010 Dec; 649(1-3):268-76. PubMed ID: 20863785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.
    Miyahara S; Kiryu J; Yamashiro K; Miyamoto K; Hirose F; Tamura H; Katsuta H; Nishijima K; Tsujikawa A; Honda Y
    Am J Pathol; 2004 May; 164(5):1697-706. PubMed ID: 15111316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
    Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
    J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay of signaling pathway in endothelial cells-matrix stiffness dependency with targeted-therapeutic drugs.
    Vania V; Wang L; Tjakra M; Zhang T; Qiu J; Tan Y; Wang G
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165645. PubMed ID: 31866415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin improves disturbed endothelial barrier function.
    van Nieuw Amerongen GP; Vermeer MA; Nègre-Aminou P; Lankelma J; Emeis JJ; van Hinsbergh VW
    Circulation; 2000 Dec; 102(23):2803-9. PubMed ID: 11104736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
    Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
    Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
    Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
    Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin in traumatic brain injury: effect on brain edema mechanisms.
    Béziaud T; Ru Chen X; El Shafey N; Fréchou M; Teng F; Palmier B; Beray-Berthat V; Soustrat M; Margaill I; Plotkine M; Marchand-Leroux C; Besson VC
    Crit Care Med; 2011 Oct; 39(10):2300-7. PubMed ID: 21666443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of statins on endothelium and signaling mechanisms.
    Endres M; Laufs U
    Stroke; 2004 Nov; 35(11 Suppl 1):2708-11. PubMed ID: 15375300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.